Government Owned Invention Available for License: Chimeric Antigen Receptors Targeting the Gamma Delta (γδ) T-Cell Receptor
The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for a s...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- July 16, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for a s...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Related coverage
More related coverage
Solarâ„¢ GI
Under extended clinical use conditions (e.g., long-duration studies), moisture generated within the...
Immunoglobulin: when to use
UK Health Security Agency's immunoglobulin handbook, providing guidance on administering immunoglobu...
Malaria prevention guidelines for travellers from the UK 2026
The UK Malaria Expert Advisory Group (formerly the Advisory Committee on Malaria Prevention) updates...
Ebola and Marburg haemorrhagic fevers: outbreaks and case locations
Information about incidents and outbreaks of Ebola and Marburg, both viral haemorrhagic fevers (VHF)...